Key result
Hospitalization in older CKD patients is linked to a ~13% reduction in potentially inappropriate medications.
Why the study?
There is a paucity of data on how hospitalization affects potentially inappropriate medication use in older adults with chronic kidney disease.
Does hospitalization reduce potentially inappropriate medication use in older adults with chronic kidney disease?
Cohort (n=204)
No
Does hospitalization reduce potentially inappropriate medication use in older adults with chronic kidney disease?
Absolute Event Rate: 48% vs 55%
p-value: p=<0.01
Hospitalization of older adults with CKD is associated with a modest but significant reduction in potentially inappropriate medication use, though PIMs remain highly prevalent at discharge.
Hospitalization was associated with modest PIM reduction in older CKD adults; leaves open whether targeted deprescribing improves discharge prevalence.
OBJECTIVES: Potentially inappropriate medication (PIM) use is associated with increased morbidity and mortality in chronic kidney disease (CKD). However, there is a paucity of data on how hospitalization affects PIM use in older adults with CKD. Therefore, we aimed to measure the impact of hospitalization on PIM use in older CKD patients, and identify factors predicting PIM use. METHODS: A retrospective cohort study was conducted in older adults (≥65 years) with CKD admitted to an Australian tertiary care hospital over a 6 month period. PIM use was measured, upon admission and at discharge, using the Medication Appropriateness Index (MAI) and Beers criteria (2015 version) for medications recommended to be avoided in older adults and under certain conditions. RESULTS: The median age of the 204 patients was 83 years (interquartile range (IQR): 76-87 years) and most were men (61%). Overall, the level of PIM use (MAI) decreased from admission to discharge (median [IQR]: 6 [3-12] to 5 [2-9]; p < .01]). More than half of the participants (55%) had at least one PIM per Beers criterion on admission, which was reduced by discharge (48%; p < .01). People admitted with a higher number of medications (β 0.72, 95% CI 0.56-0.88) and lower eGFR values (β - 0.11, 95% CI -0.18 to -0.04) had higher MAI scores after adjusting for age, sex and Charlson's comorbidity index. CONCLUSIONS: PIMs were commonly used in older CKD patients. Hospitalization was associated with a reduction in PIM use, but there was considerable scope for improvement in these susceptible individuals.
No takes yet. Share an insight, caveat, or question.
Tesfaye et al. (2018) conducted a cohort in Chronic kidney disease (n=204). Hospitalization vs. Admission (pre-hospitalization) was evaluated on Potentially inappropriate medication (PIM) use per Beers criterion (p=<0.01). Hospitalization in older adults with chronic kidney disease was associated with a reduction in potentially inappropriate medication use from 55% on admission to 48% at discharge (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: